Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical control and rates of distant metastases, when compared to standard radiotherapy.
Original Article: Higher-dose RT does not improve survival but reduces recurrence risk for prostate cancer patients
NEXT ARTICLE